» Articles » PMID: 32978497

In Vivo Assessment of the Antischistosomal Activity of Curcumin Loaded Nanoparticles Versus Praziquantel in the Treatment of Schistosoma Mansoni

Overview
Journal Sci Rep
Specialty Science
Date 2020 Sep 26
PMID 32978497
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Schistosomiasis is a serious parasitic infection affecting millions worldwide. This study aimed to explore the anti-schistosomal activity of curcumin and curcumin loaded gold-nanoparticles (Cur-GNPs) with or without praziquantel (PZQ). We used six groups of the C57BL/6 mice in which five groups were infected with Schistosoma Mansoni (S. mansoni) cercariae and exhibited, separately, to different treatment regimens of curcumin, curcumin loaded nanoparticle, and PZQ, in addition to one untreated group which acts as a control. Mice were sacrificed at the 8th week where both worms and eggs were counted in the hepatic and porto-mesenteric vessels in the liver and intestine, respectively, in addition to a histopathological examination of the liver granuloma. Curcumin caused a significant reduction in the worms and egg count (45.45%) at the 3rd week. A significant schistosomicidal effect of PZQ was found in all groups. Cur-GNPs combined with PZQ 97.4% reduction of worm burden in the 3rd week and the highest reduction in the intestinal and hepatic egg content, as well, besides 70.1% reduction of the granuloma size. The results suggested the curcumin in combination with PZQ as a strong schistosomicidal regimen against S. mansoni as it alters the hematological, biochemical, and immunological changes induced.

Citing Articles

Combinatorial Treatment with Praziquantel and Curcumin Reduces Parasite Burden and Clonorchiasis-Associated Pathologies in Rats.

Lee S, Chu K, Yoon K, Heo S, Song J, Li J Pharmaceutics. 2025; 16(12.

PMID: 39771529 PMC: 11678916. DOI: 10.3390/pharmaceutics16121550.


Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.

Soto-Sanchez J, Garza-Trevino G Pharmaceutics. 2024; 16(10).

PMID: 39458571 PMC: 11510106. DOI: 10.3390/pharmaceutics16101239.


Liver Fibrosis Is Enhanced by a Higher Egg Burden in Younger Mice Infected with .

Muller H, Strassmann J, Baier A, von Bulow V, Stettler F, Hagen M Cells. 2024; 13(19.

PMID: 39404406 PMC: 11475498. DOI: 10.3390/cells13191643.


Efficacy assessment of miltefosine and curcumin against infection.

Lee S, Chu K, Yoon K, Eom G, Mao J, Lee H Antimicrob Agents Chemother. 2024; 68(9):e0064224.

PMID: 39082882 PMC: 11373209. DOI: 10.1128/aac.00642-24.


Ovicidal activity and cytotoxicity of ethanolic extract of turmeric () and green tea () to treat digestive parasite of sheep.

Hidayatik N, Harini S, Triwidiawati N, Putri S, Proboningrat A, Kristianingtyas L Open Vet J. 2024; 14(6):1467-1475.

PMID: 39055752 PMC: 11268915. DOI: 10.5455/OVJ.2024.v14.i6.15.


References
1.
Li G, Huang S, Lian L, Song X, Sun W, Miao J . Derivation and external validation of a model to predict 2-year mortality risk of patients with advanced schistosomiasis after discharge. EBioMedicine. 2019; 47:309-318. PMC: 6796502. DOI: 10.1016/j.ebiom.2019.08.028. View

2.
Elbaz T, Esmat G . Hepatic and intestinal schistosomiasis: review. J Adv Res. 2015; 4(5):445-52. PMC: 4293886. DOI: 10.1016/j.jare.2012.12.001. View

3.
Seubert J, Pohlke R, Loebich F . Synthesis and properties of Praziquantel, a novel broad spectrum anthelmintic with excellent activity against Schistosomes and Cestodes. Experientia. 1977; 33(8):1036-7. DOI: 10.1007/BF01945954. View

4.
Doenhoff M, Cioli D, Utzinger J . Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis. 2008; 21(6):659-67. DOI: 10.1097/QCO.0b013e328318978f. View

5.
Vale N, Gouveia M, Rinaldi G, Brindley P, Gartner F, Costa J . Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. Antimicrob Agents Chemother. 2017; 61(5). PMC: 5404606. DOI: 10.1128/AAC.02582-16. View